EMA Clinical Trial Information System (CTIS) Information Day

The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition of their clinical trials to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and EU/EEA member states will share insights and best practices.

Back to Agenda

Part II - Presentations

Session Chair(s)

Marianne Lunzer, DrMed

Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care

AGES, Austria

Noemie Manent, PharmD

TDA-CTT Operations Workstream Lead

European Medicines Agency, Netherlands

Speaker(s)

Practical Insights of Transitioning Clinical Trials From Industry Sponsor Perspective

Scott Feiner

AbbVie, United States

Senior Manager, Trial Disclosure

Practical Insights of Transitioning Clinical Trials From Academia Sponsor Perspective

Leonard van den Berg

University Medical Center Utrecht (UMC) , Netherlands

Have an account?